US mulls more genetic testing oversight for FDA
This article was originally published in Clinica
Executive Summary
US health officials and their advisors are looking at setting up a regulatory system for genetic testing. It would mean that once a product passes a certain experimental threshold, it would automatically be required to undergo a form of premarket review by the US FDA.